ReviewExpert review of anticancer therapy2019

Recent advances with cyclin-dependent kinase inhibitors: therapeutic agents for breast cancer and their role in immuno-oncology.

Gabriele Di Sante et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.